Sen. Warren Sued for Pressuring Amazon to Stop Selling ‘The Truth About COVID-19’

Dr. Joseph Mercola and Ronnie Cummins, authors of “The Truth About COVID-19,” along with the book’s publisher, Chelsea Green, and Robert F. Kennedy, Jr., who wrote the foreword, today sued Warren, alleging she violated the First Amendment by pressuring Amazon to stop selling the book.

CHD Launches New eBook: ‘COVID-19 Treatment and Vaccine Decisions From a Pediatric Perspective’

Children’s Health Defense launched a new eBook to help parents evaluate the risks and benefits of COVID vaccines without having to rely solely on information disseminated by the Centers for Disease Control and Prevention, U.S. Food and Drug Administration and mainstream media.

COVID-19 Treatment and Vaccine Decisions from a Pediatric Perspective

FREE EBOOK COVID-19 Treatment and Vaccine Decisions from a Pediatric Perspective: Evaluating the risks and benefits for your child or adolescent beyond CDC, FDA or WHO proclamations Children and adolescents have been at the forefront of many discussions about COVID-19 — whether related to school closures, masking, or experimental vaccines. In this eBook, written from […]

Advocacy in a Box Campaign for COVID-19

Supporting Resources POSTCARD #1 – The COVID vaccine is NOT safe or effective VAERS COVID19 reporting Viral Loads Similar Between Vaccinated and Unvaccinated People VAERS COVID Vaccine Adverse Event Reports Virus levels high in Wisconsin COVID-19 cases, even among fully vaccinated Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings […]

Ivermectin for COVID-19: real-time meta analysis of 65 studies

Ivermectin is an effective treatment for COVID-19. Treatment is more effective when used early. Meta analysis using the most serious outcome reported shows 66% [53‑76%] and 86% [75‑92%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis and restriction to peer-reviewed studies or Randomized Controlled Trials.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests

The COVID-19 pandemic caused increased mortality in nursing homes due to its quick spread and the age-related high lethality.

Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities

The clinical experience of this case series indicates DOXY-HCQ treatment in high-risk COVID-19 patients is associated with a reduction in clinical recovery, decreased transfer to hospital, and decreased mortality were observed after treatment with DOXY-HCQ.

COVID-19 mortality risk factors in older people in a long-term care center

Male gender, low Barthel index, and lymphocytopenia are independent risk factors for COVID-19 mortality in institutionalized older patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was associated with lower mortality in these patients.

Effectiveness of a On-site Medicalization Program for Nursing Homes With COVID-19 Outbreaks

A coordinated on-site MP of nursing homes with COVID-19 outbreaks achieved a higher SOPC rate, and a reduction in referrals to hospital, thus ensuring rigorous but also humanistic and gentle care to residents.

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2 and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of hydroxychloroquine on respiratory viral loads.

Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial

This natural trial showed that the COVID-19 regimen containing both HCQ and azithromycin can be helpful to promote the recovery of most patients and reduced their signs and symptoms significantly.

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review

Evidence is not sufficiently strong to either promote or refute the efficacy of IVM, DOXY, or their combination in COVID-19 management.

Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

Ivermectin is an FDA-approved antiparasitic agent, being currently investigated in COVID-19 patients.

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

The authors declare that there are no known competing financial interests or personal relationships that could have appeared to influence the work described in this paper.

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.

Vaccinating People Who Have Had COVID-19: Why Doesn’t Natural Immunity Count in the U.S.?

The CDC estimates that SARS-CoV-2 has infected more than 100 million Americans, and evidence is mounting that natural immunity is at least as protective as vaccination. Yet public health leadership says everyone needs the vaccine.

Does the FDA Think These Data Justify the First Full Approval of a COVID-19 Vaccine?

The U.S. Food and Drug Administration should have demanded adequate, controlled studies with long-term follow up, and made data publicly available, before granting full approval to COVID-19 vaccines, says BMJ Associate editor Peter Doshi.

Did COVID-19 Leak From a Lab? The World Has a Right to Know the Truth.

The question of whether the virus leaked from a lab is not just a technical debate — it raises deep public policy, legal, ethical and cultural questions.

U.S. Health Agencies Will Decide if COVID-19 Booster Shots Are Needed – Not Vaccine Companies + More

The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.

Moderna Says Its COVID-19 Shot Works in Kids as Young as 12 + More

The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.

Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial

We examined whether existing licensed pharmacotherapies could reduce the spread of coronavirus disease 2019 (COVID-19).

Increased risk for Covid-19 in patients with Vitamin D deficiency.

Vit D deficiency increased likelihood of being COVID-19 positive by 4.6 times.

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.

Hospitalized COVID-19 patients with diabetes had a 85.7% lower death rate when given Vit D.

Nutrients, Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.

Observational study showing improved immune system activity if supplementation was given to Vit D insufficient and deficient patients.

Nutrients, High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.

An 80% decrease in death among hospitalized (late treatment) patients in the UK given Vitamin D.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests.

Italian nursing home patients given Vitamin D before being exposed to COIVD 19 had a 70% decrease in death.

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).

Early treatment of COVID-19 with sequential multidrug treatment (SMDT) that has been shown to be safe and effective for non-hospitalized patients with symptoms of COVID 19.

Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients

Patients with higher Vitamin D levels had significantly lower death rate.

COVID-19 Vaccine Reactions

The following information was submitted by individuals using our Reactions Form.

WHO Finally Admits COVID-19 PCR Test Has a ‘Problem’

The WHO’s new guidance, which includes lower PCR thresholds, almost guarantees COVID “case” numbers will automatically drop dramatically around the world.